ITMCTR2000002999招募中4 期
A randomized, open, parallel-controlled clinical trial on the efficacy and safety of Jingyebaidu granules in treating novel coronavirus pneumonia (COVID-19)
Tongji Hospital, Tongji Medical College of HUST0 个研究点开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 18 至 —（—）
- 性别
- All
入选标准
- •1. Patients who were confirmed diagnosis of 2019-ncov virus pneumonia, according to the pneumonia diagnosis and treatment program for novel coronavirus infection (trial version 5),including clinical symptoms, pulmonary CT manifestations and positive nucleic acid test;
- •2. Inpatients 18 years old (including 18), regardless of gender;
- •3. Willing to participate in this clinical trial and sign the informed consent.
排除标准
- •1. Patients with severe pneumonia requiring mechanical ventilation and severe new coronavirus infection with pneumonia;
- •2. Death is expected within 48 hours;
- •3. There is clear evidence of bacterial infection in respiratory tract infections caused by primary immunodeficiency disease, acquired immunodeficiency syndrome, congenital respiratory tract malformation, congenital heart disease, gastroesophageal reflux disease, pulmonary dysplasia and other basic diseases;
- •4 subjects with the following conditions: daily treatment of asthma, any other chronic respiratory diseases, respiratory bacterial infections such as suppurative tonsillitis, acute tracheal bronchitis, sinusitis, otitis media and other respiratory diseases that affect clinical trial evaluation.Chest CT confirmed the existence of severe pulmonary interstitial lesions, bronchiectasis and other basic pulmonary diseases;
- •5. According to the researcher's judgment, the previous or current diseases may affect the patient's participation in the trial or the outcome of the study, including malignant diseases, autoimmune diseases, severe malnutrition, liver and kidney diseases, blood diseases, nervous system diseases, and endocrine diseases;He is suffering from serious diseases that affect the immune system, such as human immunodeficiency virus (HIV) infection, or blood system, or splenectomy, organ transplantation, etc.
- •Unable to cooperate in mental state, suffering from mental disease, unable to control, unable to express clearly;
- •Allergic constitution (such as allergic to two or more drugs or food) or history of allergy to this product and conventional treatment drugs;
- •8. A history of substance abuse or dependence;
- •9. Pregnant or nursing women;
- •10. Other researchers consider it inappropriate to participate in clinical trials.
研究者
相似试验
进行中（未招募）
不适用
A clinical trial to assess the Efficacy and safety of liposomal Curcumin in subjects with metabolic syndromeCTRI/2017/06/008903CureSupport
已完成
不适用
A randomized, double blind, controlled clinical trial of S-Amlodipine versus conventional Amlodipine, to compare the incidence of leg edema and antihypertensive efficacy in patients with hypertensioHypertension, leg oedemaSLCTR/2013/006Emcure Pharmaceuticals Limited
尚未招募
2 期
A randomized, double-blind, controlled clinical trial of Suhe Granules for chronic insomnia patients with Disharmony of Qi and Blood and Deficiency of Heart and KidneyinsomniaITMCTR2200006603Guangdong Provincial Hospitai of Chinese Medicine
尚未招募
2 期
To access nutritional effect of dates in pregnancyCTRI/2024/06/068860Sanika Ashok Ghaiwat
尚未招募
1 期
Randomized, open, parallel controlled clinical study of Haiai Decoction combined with oral administration of finasteride for male androgenic alopeciaandrogenic alopeciaITMCTR2000003332Shanghai Tongji Hospital